Preeclampsia (PE) presents with maternal de novo hypertension and significant proteinuria and is one of the leading causes of maternal and perinatal morbidity and mortality with unknown etiology. The disease is associated with inflammatory vascular response and severe red blood cell (RBC) morphology changes. This study examined the nanoscopic morphological changes of RBCs from PE women versus normotensive healthy pregnant controls (PCs) and non-pregnant controls (NPCs) applying atomic force microscopy (AFM) imaging. The results revealed that the membrane of fresh PE RBCs differed significantly from healthy ones by the presence of invaginations and protrusions and an increased roughness value (Rrms) (4.7 ± 0.8 nm for PE vs. 3.8 ± 0.5 nm and 2.9 ± 0.4 nm for PCs and NPCs, respectively). PE-cells aging resulted in more pronounced protrusions and concavities, with exponentially increasing Rrms values, in contrast to the controls, where the Rrms parameter decreased linearly with time. The Rrms, evaluated on a 2 × 2 µm2 scanned area, for senescent PE cells (13 ± 2.0 nm) was significantly higher (p < 0.01) than that of PCs (1.5 ± 0.2 nm) and NPCs (1.9 ± 0.2 nm). Furthermore, the RBCs from PE patients appeared fragile, and often only ghosts were observed instead of intact cells at 20–30 days of aging. Oxidative-stress simulation on healthy cells led to RBC membrane features similar to those observed for PE cells. The results demonstrate that the most pronounced effects on RBCs in PE patients are related to impaired membrane homogeneity and strongly altered roughness values, as well as to vesiculation and ghost formation in the course of cell aging.
Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) secrete a rich array of paracrine factors including growth factors, cytokines, and extracellular vesicles that hold promises for regenerative medicine. This study evaluated the effects of WJ-MSC-derived secretome on adipose-derived mesenchymal stem cells (AD-MSCs) and human dermal fibroblasts (HDFs), focusing on their adhesion, spreading, proliferation, endogenous collagen secretion, and migration. Morphometric analysis revealed that the secretome enhanced cell adhesion and spreading on rat tail collagen (RTC) substrates after 24 h. AD-MSCs showed a ~30% increase in the cell spreading area (from 4007 μm2 to 5081 μm2p < 0.05), though without notable shape changes. In contrast, fetal bovine serum (FBS) promoted cell elongation with a reduced aspect ratio. Proliferation assays demonstrated a selective stimulatory effect of the secretome on AD-MSCs with a significant increase at day 3, while HDFs’ proliferation remained unchanged. Cell cycle profiling showed transient S-phase accumulation in AD-MSCs (24–48 h), followed by G0/G1 arrest (72 h), while HDFs remained in G0/G1. Immunofluorescence analysis confirmed the enhanced extracellular deposition of endogenously synthesized collagen in AD-MSCs, while no comparable response was observed in HDFs. Scratch assays showed increased migration in both cell types upon secretome exposure compared to collagen-only controls, suggesting a paracrine-mediated pro-migratory effect. These results demonstrate that WJ-MSC secretome boosts the regenerative capacity in AD-MSCs while keeping fibroblasts quiescent, highlighting its strong potential for cell-free therapies in tissue engineering, wound repair, and regenerative medicine.
Wharton’s Jelly-derived mesenchymal stem cells (WJ-MSCs) secrete a rich array of paracrine factors including growth factors, cytokines, and extracellular vesicles that hold promises for regenerative medicine. This study evaluated the effects of WJ-MSC-derived secretome on adipose-derived mesenchymal stem cells (AD-MSCs) and human dermal fibroblasts (HDFs), focusing on their adhesion, spreading, prolifer-ation, endogenous collagen secretion, and migration. Morphometric analysis revealed that the secretome enhanced cell adhesion and spreading on rat tail collagen (RTC) substrates after 24 hours. AD-MSCs showed a ~30% increase in cell spreading area (from 4007 μm² to 5081 μm² p < 0.05), though without notable shape changes. In contrast, fetal bovine serum (FBS) promoted cell elongation with reduced aspect ratio. Proliferation assays demonstrated a selective stimulatory effect of the secretome on AD-MSCs, with a significant increase at day 3, while HDFs’ proliferation remained unchanged. Cell cycle profiling showed transient S-phase accumulation in AD-MSCs (24-48h), followed by G0/G1 arrest (72h), while HDFs remained in G0/G1. Immunofluorescence analysis confirmed enhanced extracellular deposition of endogenously synthesized collagen in AD-MSCs, while no comparable response was observed in HDFs. Scratch assays showed increased migration in both cell types upon secretome exposure, compared to collagen-only controls, suggesting a paracrine-mediated pro-migratory effect. These results demonstrate that WJ-MSC secretome boosts regenerative capacity in AD-MSCs while keeping fibroblasts quiescent, highlighting its strong potential for cell-free therapies in tissue engineering, wound repair, and regenerative medicine.
The design of multifunctional biomaterials that offer both structural support and biochemical cues is essential for enhancing tissue regeneration. In this study, hybrid nanofibrous scaffolds composed of poly(L-lactide-co-ε-caprolactone) (PLCL) and bioactive factors secreted by Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) were fabricated via co-electrospinning. Nanofibers were produced in aligned and random configurations following an optimized protocol developed at the Institute for Bioengineering of Catalonia (IBEC). Their morphology and topography were characterized by light microscopy, scanning electron microscopy (SEM), and atomic force microscopy (AFM), and fiber orientation was quantified via Fast Fourier Transform (FFT) analysis. The scaffolds showed fiber diameters of 542.9 ± 62.3 nm, with aligned fibers predominantly oriented within 20° of the principal axis. Human AD-MSCs were used to assess biocompatibility and cell–material interactions. Aligned and random nanofiber architectures elicited distinct cellular responses. AD-MSCs on aligned fibers exhibited smaller spreading areas (~320 μm2) vs. on random nanofibers (~500 μm2) and substantially higher proliferation, resulting in a shorter cell-doubling time (~25 h) than those on random nanofibers (~130 h) or control substrates (~70 h). In addition, aligned nanofibers promoted markedly faster migration, reaching rates of ~5000 μm2/h surface coverage, compared with random nanofibers (~770 μm2/h) and controls (~1800 μm2/h). Together, the results show that nanofiber alignment and biochemical functionalization jointly influence MSC behavior and improve regeneration, highlighting the potential of these PLCL-based hybrid secretome/PLCL nanofibers for advanced wound healing.
The design of multifunctional biomaterials that offer both structural support and bio-chemical cues is essential for enhancing tissue regeneration. In this study, hybrid nan-ofibrous scaffolds composed of poly(L-lactide-co-ε-caprolactone) (PLCL) and bioactive factors secreted by Wharton’s jelly-derived mesenchymal stem cells (WJ-MSCs) were fabricated via co-electrospinning. Nanofibers were produced in both aligned and ran-dom configurations following an optimized protocol developed at the Institute for Bi-oengineering of Catalonia (IBEC). Morphological and topographical features were characterized using light microscopy and atomic force microscopy (AFM), while fiber orientation was quantitatively assessed through Fast Fourier Transform (FFT) analysis. The controlled release kinetics of FITC-labeled bioactive compounds were evaluated, and human adipose-derived MSCs (AD-MSCs) were used as a cell model to evaluate scaffold biocompatibility, in respect to cell viability, adhesion, proliferation, and mi-gration. FFT analysis was also applied to quantify the orientation of AD-MSCs when cultured on the nanofibers, revealing higher cellular anisotropy and alignment on ori-ented scaffolds. We further show that aligned nanofibers supported cell viability and proliferation, as well as directed migration as wound closure assays showed signifi-cantly faster healing on aligned nanofibers compared to random ones. These results emphasize the synergistic effects of nanofiber alignment and biochemical functionali-zation in modulating cell behavior and promoting tissue regeneration, underscoring the potential of PLCL-based hybrid nanofibers for advanced wound healing applications.
The tumor microenvironment is continuously shaped by reciprocal interactions between malignant cells and stromal components, with mesenchymal stem cells (MSCs) serving as key regulators of extracellular matrix (ECM) deposition and remodeling. In this study, we examined how cancer cell-derived secretomes from two hematological cancer cell lines, RPMI 8226 (multiple myeloma) and HG-3 (B-cell leukemia), influence the functional behavior of human adipose-derived MSCs (AD-MSCs). Exposure to these secretomes altered MSC proliferative capac-ity (2x faster doubling compared to the control), induced senescence (~3-4x higher than that of the control), and significantly modified MSC mediated colla-gen remodeling, as quantified using FITC-collagen coated substrata. Tumor con-ditioned media also reduced MSC spreading area (~2100 µm2 compared to the control ~2500 µm2) and induced distinct morphological changes indicative of a possible shift toward a cancer associated stromal phenotype. To assess the stabil-ity of these changes, MSCs were analyzed following a withdrawal of the cancer cell secretomes and further cultured in secretome-free environment, which re-vealed that most phenotypic and functional alterations were maintained and that the reprogramming is partially irreversible. These findings also demonstrate that the paracrine factors released by RPMI 8226 and HG-3 cells modulate MSC func-tionality upon interaction with collagen, providing insight into stromal contribu-tions to tumor progression.